Skip to content
Peptigraph home

Is 5-Amino-1MQ Legal? FDA, Compounding and WADA Status

5-Amino-1MQ's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingNNMT inhibitor (not a peptide)Updated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Unclear
Not named on the 2026 list
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. 5-Amino-1MQ is not FDA approved for any use.

5-Amino-1MQ: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "5-amino-1MQ" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to 5-Amino-1MQ found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

Sport and drug testing

WADA status unclear

5-Amino-1MQ is not named. S4.4 covers AMPK activators, PPAR-delta agonists and Rev-erb agonists by example, and nothing there names an NNMT inhibitor. This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

5-Amino-1MQ: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "5-amino-1MQ" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "5-amino-1MQ" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "5-amino-1MQ" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

What the regulator searches for 5-amino-1MQ returned

FDA's Drugs@FDA database has no application listing 5-amino-1MQ as an active ingredient: the search came back with a not-found error.[2]

The UK electronic Medicines Compendium search for 5-amino-1MQ returned no medicine.[3]

Health Canada's Drug Product Database returned no active-ingredient record for 5-amino-1MQ.[4]

Australia's ARTG register found no matching entry for 5-amino-1MQ.[5]

Australian enforcement and the sport list

Australia's drug regulator said in June 2026 that it is prioritising compliance action against unapproved peptide products, a statement about peptides in general, not 5-amino-1MQ by name.[7]

The current WADA list does not name 5-amino-1MQ, but its catch-all class S0 covers any drug with no approval for human therapeutic use by any health authority.[1]

Common questions

Is 5-amino-1MQ FDA approved?

No approved product turned up: the Drugs@FDA search for 5-amino-1MQ returned an error saying no match was found.[2]

Is 5-Amino-1MQ legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is 5-Amino-1MQ banned by WADA?

It is unclear. 5-Amino-1MQ is not named. S4.4 covers AMPK activators, PPAR-delta agonists and Rev-erb agonists by example, and nothing there names an NNMT inhibitor. This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Is 5-amino-1MQ legal?

This page records only what regulators' databases show: none of the four searched (US, UK, Canada, Australia) lists an approved 5-amino-1MQ product, and it does not give legal advice.[5]

More on 5-Amino-1MQ

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "5-amino-1MQ" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "5-amino-1MQ" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  4. 4Canada: No product found in a Health Canada Drug Product Database search for ingredient "5-amino-1MQ" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  5. 5Australia: No approved product found in an ARTG search for "5-amino-1MQ" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  6. 6EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  7. 7TGA strengthens compliance focus on unapproved peptide products as part of evolving risk responseTherapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026

Found an error? Report a correction.